NCT05598632 Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
| NCT ID | NCT05598632 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China National Center for Cardiovascular Diseases |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 22,000 participants |
| Start Date | 2023-04-18 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 22,000 participants in total. It began in 2023-04-18 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older; male or female. * History of documented atrial fibrillation. * Able to provide written informed consent. Exclusion Criteria: * Subjects with moderate or severe mitral stenosis or a mechanical heart valve * Subjects with previous or planned AF ablation. * Subjects with previous or planned left atrial appendage closure. * Subjects unable to cooperate with follow-up after assessment.
Contact & Investigator
Zhe Zheng, MD, PhD
STUDY CHAIR
Fuwai Hospital, Chinese Academy of Medical Science
Frequently Asked Questions
Who can join the NCT05598632 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05598632 currently recruiting?
Yes, NCT05598632 is actively recruiting participants. Contact the research team at zhengzhe@fuwai.com for enrollment information.
Where is the NCT05598632 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05598632 clinical trial?
NCT05598632 is sponsored by China National Center for Cardiovascular Diseases. The principal investigator is Zhe Zheng, MD, PhD at Fuwai Hospital, Chinese Academy of Medical Science. The trial plans to enroll 22,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.